Appointments
+(603) 5515 1966
General Line
+(603) 5515 1888
December 14, 2024
Uterine cancer, a condition that begins in the uterus – the hollow organ in a woman’s pelvis where fetal development occurs during pregnancy – is one of the most common gynaecological cancers. Understanding this disease can help in early detection, effective treatment, and improved survival rates.
This article delves deep into uterine cancer, covering its symptoms, causes, stages, treatment options, prevention strategies, and prognosis.
Uterine cancer is a type of cancer that originates in the uterus, a pear-shaped organ in the female pelvis where a fetus develops during pregnancy.
This condition occurs when cells in the uterus grow uncontrollably and form a tumour, which can be benign (non-cancerous) or malignant (cancerous).
Uterine cancer is primarily classified into two main types:
Endometrial cancer is the most prevalent type, representing over 90% of uterine cancer cases. It originates in the endometrium, the lining of the uterus. This type of cancer is frequently linked to hormonal imbalances, specifically elevated levels of estrogen.
A less common type of uterine cancer, known as uterine sarcoma, originates in the muscle or connective tissues of the uterus. This form of cancer is typically more aggressive and poses greater challenges in terms of treatment when compared to endometrial cancer.
The symptoms of uterine cancer can vary depending on the stage and type of cancer. Early detection is crucial, as the disease is more treatable in its initial stages. Here are the most common symptoms to watch for:
The exact causes of uterine cancer are not fully understood, but researchers have identified several factors that increase the likelihood of developing this condition. These causes and risk factors often relate to hormonal imbalances, lifestyle, genetics, and underlying health conditions.
Uterine cancer begins when genetic mutations occur in the cells of the uterus. These mutations cause cells to grow uncontrollably, form a tumour, and potentially spread to other parts of the body. Factors contributing to these mutations often include:
An imbalance of estrogen compared to progesterone can result in the excessive growth of the endometrial lining, which in turn raises the likelihood of developing endometrial cancer. Factors such as obesity or polycystic ovary syndrome (PCOS) can disturb this delicate equilibrium.
Certain cases of uterine cancer are associated with inherited genetic mutations, specifically in conditions such as Lynch syndrome.
Exposure to specific chemicals or leading a sedentary lifestyle can increase the risk of developing cancer.
So what are the factors that increase the woman’s risk of developing uterine cancer? Here are a few:
Utilising estrogen alone for hormone replacement therapy (HRT) can increase the risk of certain health issues. Prolonged exposure to estrogen throughout one’s lifetime can further elevate this risk. Conversely, pregnancy can decrease the number of menstrual cycles and exposure to estrogen, ultimately reducing the risk of developing these health issues.
Adipose tissue can convert various hormones into estrogen, thereby elevating estrogen levels within the body. This process is particularly significant in individuals who are obese, as they are at a threefold higher risk of developing uterine cancer.
The majority of uterine cancers typically develop after menopause, with a higher incidence among women aged 50 and above.
A family history of uterine, colon, or ovarian cancer can increase the risk of developing these types of cancers. Lynch syndrome, a genetic condition, is specifically linked to an increased risk of uterine cancer.
Polycystic Ovary Syndrome (PCOS) is a condition that results in chronic hormonal imbalance. Diabetes, often associated with obesity, is a significant risk factor for individuals with PCOS. Additionally, individuals with PCOS are at risk for developing Endometrial Hyperplasia, a condition characterised by the thickening of the uterine lining which can potentially lead to cancer.
A sedentary lifestyle and lack of physical activity are major contributors to obesity and other health risks. Additionally, high-fat diets can impact hormone levels and increase the risk of developing certain conditions. Furthermore, habits such as alcohol consumption and smoking can also play a significant role in the development of cancer. It is important to be mindful of these factors and make healthy choices to reduce the risk of these health issues.
Women who have been treated for ovarian cancer may have an increased risk of developing uterine cancer. This heightened risk is often attributed to the damage that pelvic radiation can cause to uterine cells, potentially leading to the development of cancer over time.
Early and accurate diagnosis of uterine cancer is essential for successful treatment and better outcomes. If symptoms like abnormal vaginal bleeding or pelvic pain occur, healthcare providers use a combination of diagnostic tools to confirm the presence of uterine cancer, determine its type, and evaluate its stage.
To visualise the uterus and measure the thickness of the endometrial lining, a small device is inserted into the uterus to produce detailed images. An abnormally thick endometrium in postmenopausal women may be indicative of cancer or pre-cancerous conditions.
In order to conduct a microscopic examination of cells from the uterine lining, a thin and flexible tube is inserted into the uterus through the cervix to collect tissue samples. This method is considered the most reliable and accurate way to diagnose endometrial cancer.
This procedure offers a direct visualisation of the uterine cavity by inserting a thin, illuminated tube equipped with a camera through the vagina and cervix. It enables precise biopsies of any suspicious areas within the uterus.
If cancer is confirmed, imaging tests may be utilised to evaluate the extent and spread of the disease. These tests include:
These imaging tests play a crucial role in determining the stage of cancer and developing an appropriate treatment plan.
In cases where biopsy results are inconclusive, it may be necessary to remove and examine more extensive tissue samples. This procedure involves dilating the cervix and gently scraping the uterine lining to collect tissue for further analysis. It is commonly performed as a follow-up to an abnormal biopsy result.
Although there is no specific test for uterine cancer, there are some general tests that can help evaluate overall health and identify abnormalities. These tests include:
These tests are important tools in the early detection and monitoring of uterine cancer. By regularly undergoing these tests, individuals can take proactive steps towards maintaining their health and well-being.
Any cancer, including uterine cancer, is graded into stages. Staging determines the extent of cancer spread and acts as a guide for developing the treatment plan:
The cancer is confined to the endometrium or has infiltrated less than half of the myometrium (uterine muscle). If the cancer has spread to more than half of the myometrium but is still contained within the uterus.
Cancer has spread to the cervical stroma from the uterus but has not extended beyond the uterus.
The cancer has metastasised to the outer layer of the uterus (serosa), ovaries, or fallopian tubes, as well as nearby tissues. Additionally, the cancer has affected the lymph nodes in the pelvis or near the aorta.
Cancer has infiltrated the bladder. Additionally, it has spread to distant organs, including the lungs, liver, and bones.
The prognosis of uterine cancer varies with its stage at diagnosis.
Treatment for uterine cancer depends on factors such as the cancer’s type, stage, overall health, and personal preferences. The goal is to eliminate the cancer while preserving as much quality of life as possible. For treatment, usually, a combination of surgical, medical, and supportive therapies is often employed.
Surgery is the main treatment for uterine cancer, with the type depending on the cancer’s stage. Options include hysterectomy, removal of ovaries and fallopian tubes, lymphadenectomy, debulking surgery, and minimally invasive procedures such as laparoscopic or robotic-assisted surgery.
Radiation therapy uses high-energy beams to destroy cancer cells either before or after surgery or as a primary treatment. It includes external beam radiation therapy (EBRT) and brachytherapy, which places radioactive material directly inside the body for targeted treatment.
Hormone therapy is used to slow the growth of uterine cancer cells sensitive to hormones such as progestins, tamoxifen, and aromatase inhibitors which help counteract estrogen’s effects and block estrogen receptors.
Chemotherapy is used for advanced-stage uterine cancer or when cancer has spread beyond the uterus. It involves using drugs to destroy cancer cells or stop their growth.
Targeted therapy focuses on specific molecules involved in cancer growth, offering a more precise treatment with fewer side effects than chemotherapy.
Immunotherapy is an innovative cancer treatment that uses the immune system to fight cancer by blocking proteins that inhibit immune response. PD-1 inhibitors like pembrolizumab show promise in targeting and destroying cancer cells, providing hope for more effective and personalised treatment options.
Uterine cancer is a serious condition, but early detection, advances in treatment, and proactive prevention can significantly improve outcomes. If you or a loved one experience symptoms like abnormal vaginal bleeding, pelvic pain, or leg pain, consult a healthcare provider immediately. Regular screenings, a healthy lifestyle, and staying informed about your body are crucial steps in protecting yourself against uterine cancer.
Stay vigilant, prioritize your health, and spread awareness to empower others to do the same.
The symptoms of uterine cancer include abnormal vaginal bleeding, pelvic pain, unusual discharge, and, in advanced cases, leg pain or swelling.
Yes, uterine cancer can often be cured, especially when detected and treated in its early stages.
Women who are overweight, have a history of hormonal imbalances or are over the age of 50 are at higher risk for uterine cancer.
The first stage of uterine cancer (Stage 1) is when the cancer is confined to the uterus.
Sources:
Spread the love, follow us on our social media channels